An epitope of Bacillus anthracis protective antigen that is cryptic in rabbits may be immunodominant in humans.
作者信息
Ingram Rebecca J, Chu Karen K, Metan Gökhan, Maillere Bernard, Doganay Mehmet, Ozkul Yusuf, Dyson Hugh, Williamson E Diane, Baillie Les, Kim Louise U, Ascough Stephanie, Sriskandan Shiranee, Altmann Daniel M
出版信息
Infect Immun. 2010 May;78(5):2353; author reply 2353-4. doi: 10.1128/IAI.00072-10.
Abstract
摘要
相似文献
1
An epitope of Bacillus anthracis protective antigen that is cryptic in rabbits may be immunodominant in humans.
Infect Immun. 2010 May;78(5):2353; author reply 2353-4. doi: 10.1128/IAI.00072-10.
2
Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.
Mol Immunol. 2009 Jun;46(10):2107-15. doi: 10.1016/j.molimm.2008.12.031. Epub 2009 Apr 7.
3
[Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
Mol Gen Mikrobiol Virusol. 2007(3):15-21.
4
Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.
PLoS Pathog. 2014 May 1;10(5):e1004085. doi: 10.1371/journal.ppat.1004085. eCollection 2014 May.
5
Host immunity to Bacillus anthracis lethal factor and other immunogens: implications for vaccine design.
Expert Rev Vaccines. 2015 Mar;14(3):429-34. doi: 10.1586/14760584.2015.981533. Epub 2014 Nov 17.
6
A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
Infect Immun. 2005 Feb;73(2):795-802. doi: 10.1128/IAI.73.2.795-802.2005.
7
Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen.
Vaccine. 2015 May 11;33(20):2342-6. doi: 10.1016/j.vaccine.2015.03.037. Epub 2015 Mar 26.
8
Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
PLoS One. 2015 Jul 24;10(7):e0130952. doi: 10.1371/journal.pone.0130952. eCollection 2015.
9
BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.
J Appl Microbiol. 2020 Aug;129(2):443-452. doi: 10.1111/jam.14624. Epub 2020 Mar 18.
10
Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
Biologicals. 2019 Sep;61:38-43. doi: 10.1016/j.biologicals.2019.07.004. Epub 2019 Aug 13.
引用本文的文献
1
Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.
Vaccine. 2015 Jan 9;33(3):430-6. doi: 10.1016/j.vaccine.2014.11.042. Epub 2014 Nov 30.
2
Exposure to anthrax toxin alters human leucocyte expression of anthrax toxin receptor 1.
Clin Exp Immunol. 2013 Jul;173(1):84-91. doi: 10.1111/cei.12090.
3
Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax.
Clin Vaccine Immunol. 2013 Mar;20(3):341-9. doi: 10.1128/CVI.00612-12. Epub 2013 Jan 2.
4
CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis.
Eur J Immunol. 2011 Jan;41(1):107-15. doi: 10.1002/eji.201040881. Epub 2010 Dec 3.
5
Reverse vaccinology: developing vaccines in the era of genomics.
Immunity. 2010 Oct 29;33(4):530-41. doi: 10.1016/j.immuni.2010.09.017.
本文引用的文献
1
A heterologous helper T-cell epitope enhances the immunogenicity of a multiple-antigenic-peptide vaccine targeting the cryptic loop-neutralizing determinant of Bacillus anthracis protective antigen.
Infect Immun. 2009 Dec;77(12):5509-18. doi: 10.1128/IAI.00899-09. Epub 2009 Oct 5.
2
Synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen.
Infect Immun. 2009 Aug;77(8):3380-8. doi: 10.1128/IAI.00358-09. Epub 2009 Jun 1.
3
Antibody recognition of a highly conserved influenza virus epitope.
Science. 2009 Apr 10;324(5924):246-51. doi: 10.1126/science.1171491. Epub 2009 Feb 26.
4
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses.
Nat Struct Mol Biol. 2009 Mar;16(3):265-73. doi: 10.1038/nsmb.1566. Epub 2009 Feb 22.
5
An immunologically cryptic epitope of Plasmodium falciparum circumsporozoite protein facilitates liver cell recognition and induces protective antibodies that block liver cell invasion.
J Biol Chem. 2005 May 27;280(21):20524-9. doi: 10.1074/jbc.M414254200. Epub 2005 Mar 21.
6
Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation.
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13147-51. doi: 10.1073/pnas.0405405101. Epub 2004 Aug 23.
7
Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization.
J Virol. 1994 Sep;68(9):6006-13. doi: 10.1128/JVI.68.9.6006-6013.1994.
8
The requirement of more than one antigenic determinant for immunogenicity.
J Exp Med. 1969 Jun 1;129(6):1131-43. doi: 10.1084/jem.129.6.1131.
Zotero 插件